Growth Metrics

Travere Therapeutics (TVTX) Long-Term Debt Repayments (2016 - 2022)

Travere Therapeutics' Long-Term Debt Repayments history spans 7 years, with the latest figure at $211.3 million for Q1 2022.

  • For Q1 2022, Long-Term Debt Repayments changed N/A year-over-year to $211.3 million; the TTM value through Dec 2022 reached $211.3 million, changed N/A, while the annual FY2025 figure was $68.9 million, N/A changed from the prior year.
  • Long-Term Debt Repayments reached $211.3 million in Q1 2022 per TVTX's latest filing, up from -$39.2 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $211.3 million in Q1 2022 to a low of -$39.2 million in Q4 2018.